Aortic stenosis is one of the most common and serious heart valve disease problems. However, many patients are unaware or undiagnosed, which is why the 91ÊÓƵ continues to drive efforts for timely diagnosis, appropriate treatment, improved quality of care initiatives and comprehensive patient and caregiver resources to combat the disease.
To tackle the problem, we have launched Target: Aortic Stenosis. The goal of the Target: Aortic Stenosis program is to enhance the patient experience from symptom onset to appropriate diagnosis and follow-through, to timely treatment and disease management. The program consists of evidence-based measurement development to better identify and treat patients, as well as multi-media educational resources and self-management care plans for people living with structural heart disease.
Resources
Sponsor
Edwards Lifesciences is the national sponsor of 91ÊÓƵ’s Target: Aortic Stenosis.